Melanoma Research Alliance (MRA): Acral Melanoma Research - LOI

Aim: research that will lead to therapeutic targeting of acral melanomas. Priority will be given to proposals that focus on NF1 loss, TERT promoter alterations, CCND1 and/or CRKL amplification. Funding: Team Science-$300K/yr for 3 years; Young Investigator-$75K/yr for 3 years. Please contact Research Authority if planning to submit (Overhead, Non-profit).

https://www.curemelanoma.org/research/request-for-proposals